Evaluation of antimalarial prescription at our two study sites.

Table 3: Evaluation of antimalarial prescription at our two study sites.

Socio-demographic data of the prescribers		Kangaba		Bougouni
Socio-demographic data of the prescribers		n	%	n	%
Age ranges	0-5 years-old	58	27.6	27	30
	6-8 years-old	12	5.7	3	3.3
	9-13 years-old	10	4.8	5	5.6
	> 13-years-old	130	61.9	55	61.1
	Total	210	100	90	100
Gender	Male	99	47.1	39	43.3
Gender	Female	111	52.9	51	56.7
Qualification	Physician	5	16.7	4	26.7
	Nurse	16	53.3	10	66.7
	Midewife	9	30	1	6.6
	Total	30	100	15	100
Awareness of the new protocol	Yes	14	47	6	40
	No	16	53	9	60
	Total
Malaria diagnostic confirmed by RDT and/or thick blood smear	Yes	175	83.3	79	87.8
	No	35	16.7	11	12.2
	Total
Antimalarial drugs for uncompleted malaria treatment	Recommended ACT	69	32.9	42	46.7
	Other ACTs	0	0	4	4,4
	Monotherapy	141	67.1	44	48.9
	Total
Recommended dosage ACTs	Conform	62	89.9	31	73.8
	Non conform	7	10.1	11	26.2
	Total
Malaria treatment duration	Conform	69	100	40	95.2
	Non conform	0	0	2	4.8
	Total